A team of experts from the European consortium LIVERSCREEN, led by IDIBAPS and funded by the Horizon 2020 programme (847989) has published the first1
Researchers from Hospital Clínic-IDIBAPS and the CIBER Hepatic and Digestive Diseases (CIBEREHD) have led a European study to evaluate the efficacy o1
New research reveals how albumin improves B cell function and enhances neutrophil antimicrobial capabilities, reducing infection risk in vulnerable p1
In this perspective article published in Nature Reviews Gastroenterology & Hepatology the authors, experts in the subject, extract the lessons learne1
The project, funded by the European Union and endowed with a budget of 24.8 million euros, aims to identify a large set of biomarkers that allow live1
Researchers at the Hospital Clínic-IDIBAPS led an international study, published in the journal The Lancet, in which they designed an index to determ1
The consortium has begun the second clinical trial to evaluate the efficiency of the combined treatment of simvastatin and the antibiotic rifaximin,1
This analysis, the largest conducted to date and led by Hospital Clínic–IDIBAPS researchers, provides evidence of the inefficacy of this therapeutic1
A study carried out entirely at the Hospital Clínic - IDIBAPS has determined that mitochondrial function in the metabolism of white blood cells is cl1
